Bausch Health launched two $750 million offerings to repurchase $1.5 billion in aggregate principal on notes due in 2023.
What you should know:
1. Bausch split the notes so half will be due in 2028 and half will be due in 2029.
2. Bausch's outstanding 2023 senior notes are at 5.5 percent and 5.88 percent interest.
3. Bausch CEO Joseph Papa has made significant strides in recent years to pay down the company's large amount of debt. Bausch Health was previously known as Valeant Pharmaceuticals.